معرفی
Carl Sandén is a Researcher at Lund University Cancer Centre (LUCC) and an Associate Researcher in the Division of Clinical Genetics and Translational Genomic and Functional Studies of Leukemia at Lund University. His work primarily centers on genomic and molecular studies of leukemia, with a focus on identifying therapeutic vulnerabilities and understanding disease mechanisms.
His research interests include
- Genomics
- Molecular biology of leukemia
- Immunology
- Proteomics
Recent publications highlight advances in
- Single-cell sequencing for leukemia subtypes
- Targeted therapies (e.g., C3AR inhibitors, IL1RAP targeting)
- Synthetic lethality in STAG2-mutated AML
- Immune T-cell dynamics in TP53-mutated AML
He contributes to collaborative projects such as Genomic and proteomic analyses of acute leukemia and participates in LUCC-led workshops on AML research.
۰مقاله منتشرشده
